Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	92.97	113.53	145.09	270.11	258.99	259.04
Cash & Short-Term Investments	92.97	113.53	145.09	270.11	258.99	259.04
Cash Growth	-18.66%	-21.75%	-46.28%	4.29%	-0.02%	38.52%
Accounts Receivable	62.28	69.06	139.63	73.14	153.16	158.76
Other Receivables	68.86	25.92	39.26	52.59	66.3	21.53
Receivables	131.14	94.99	178.89	125.73	219.45	180.29
Inventory	175.43	187.33	236.43	170.4	197.87	209.95
Prepaid Expenses	-	0.38	0.43	-	-	-
Other Current Assets	40.72	46.85	48.51	104.22	43.59	59.7
Total Current Assets	440.26	443.07	609.35	670.46	719.9	708.98
Property, Plant & Equipment	1,016	1,022	987.29	950.53	989.88	904.23
Long-Term Investments	4.97	4.97	5.3	5.95	10.98	19.6
Goodwill	13.5	13.5	20.05	18.89	18.89	308.65
Other Intangible Assets	147.7	139.86	160.33	167.55	202.68	163.73
Long-Term Deferred Tax Assets	50.28	50.65	42.3	47.9	25.94	31.03
Long-Term Deferred Charges	81.83	77.87	81.02	75.21	72.86	72.73
Other Long-Term Assets	258.23	223.65	259.98	351.98	417.66	404.72
Total Assets	2,013	1,976	2,166	2,288	2,459	2,614
Accounts Payable	51.25	66.26	78.02	57.4	112.33	110.36
Accrued Expenses	7.92	39.74	44.29	43.8	30.47	30.68
Short-Term Debt	161.34	171.08	139.89	133.22	148.5	297.58
Current Portion of Long-Term Debt	108.88	110.51	36.77	107.05	100.78	-
Current Portion of Leases	-	0.46	-	-	-	-
Current Income Taxes Payable	8.63	3.03	16.27	3.77	4.16	9.54
Current Unearned Revenue	30.05	42.21	10.79	95.66	26.1	23.85
Other Current Liabilities	146.5	62.39	54.56	63.61	62.59	108.77
Total Current Liabilities	514.56	495.68	380.59	504.51	484.92	580.78
Long-Term Debt	239.04	210	324.98	342.85	343.52	324.5
Long-Term Leases	18.83	18.65	-	-	-	-
Long-Term Unearned Revenue	50.87	51.63	48.18	51	35.61	36.72
Long-Term Deferred Tax Liabilities	34.52	34.58	33.86	34.6	41.09	41.83
Other Long-Term Liabilities	-	-	-	-	-	28.1
Total Liabilities	857.82	810.53	787.6	932.96	905.14	1,012
Common Stock	455.12	455.12	450	450	450	450
Additional Paid-In Capital	842.99	842.99	836.49	818.96	818.96	819.94
Retained Earnings	-219.62	-209.93	6.28	-5.25	182.34	180.35
Comprehensive Income & Other	51.73	51.73	51.98	52.47	52.65	52.17
Total Common Equity	1,130	1,140	1,345	1,316	1,504	1,502
Minority Interest	24.83	25.4	33.26	39.33	49.69	99.29
Shareholders' Equity	1,155	1,165	1,378	1,356	1,554	1,602
Total Liabilities & Equity	2,013	1,976	2,166	2,288	2,459	2,614
Total Debt	528.09	510.7	501.64	583.12	592.8	622.07
Net Cash (Debt)	-435.12	-397.17	-356.55	-313.01	-333.8	-363.03
Net Cash Per Share	-0.95	-0.87	-0.79	-0.70	-0.74	-0.81
Filing Date Shares Outstanding	455.12	455.12	450	450	450	450
Total Common Shares Outstanding	455.12	455.12	450	450	450	450
Working Capital	-74.3	-52.61	228.76	165.95	234.98	128.2
Book Value Per Share	2.48	2.50	2.99	2.92	3.34	3.34
Tangible Book Value	969.03	986.56	1,164	1,130	1,282	1,030
Tangible Book Value Per Share	2.13	2.17	2.59	2.51	2.85	2.29
Buildings	-	1,054	872.16	860.84	362.09	342.42
Machinery	-	398.28	383.47	381.58	289.25	340.83
Construction In Progress	-	12.03	145.62	59.59	659.28	572.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.